Researchers Say Brain Region Responsible for Pain's Ability to Seek Attention
Researchers have identified the brain region responsible for pain's ab...The new study has found that this pain-related brain region is d...The study was conducted by a team of researchers led by Ulrike B...As part of the study the researchers conducted cognitive task i...The researchers asked the volunteers to perform the tasks as the...
Researchers have identified the brain region responsible for pain's ability to seek attention.
The new study has found that this pain-related brain region is distinct from the one involved in cognitive processing interference due to a distracting memory task.
The study was conducted by a team of researchers led by Ulrike Bingel at the the University Medical Center Hamburg-Eppendorf.
As part of the study, the researchers conducted cognitive task involving distinguishing images, as well as a working memory task involving remembering images on volunteers.
The researchers asked the volunteers to perform the tasks as they experienced different levels of pain caused by the zapping of their hands by a harmless laser beam.
Researchers scanned the volunteers' brains during the tasks using functional magnetic resonance imaging (fMRI) which uses harmless magnetic fields and radio waves to scan the brain to determine blood flow across regions, which reflects brain activity.
Researchers identified a brain region called the lateral occipital complex (LOC) as the cognitive-related area affected by both 'working memory load' and pain.
The researchers then sought to identify the brain region by which pain affects the functioning of the LOC.
The study theorized that the best candidate for this region was one called the rostral anterior cingulate cortex (rACC) known to be involved in the brain's processing of pain and plays an important role in 'executive" functions such as attentional control.
The fMRI scans indicated that the region was indeed, the brain centre through which pain influences the LOC.
By contrast, they found that a working memory load affects the LOC through a different region, the inferior parietal cortex.
The findings of the study were published in the July issue of the journal Neuron, published by Cell Press.< '"/>
(Date:12/4/2009)...NGTON, Dec. 4 In respon... Agency,s (DEA) classification of boldione, desoxy...nedione as "anabolic steroids", under the Controll...tor and CEO of the Natural Products Association (N...resenting retailers and manufacturers of dietary s...
(Date:12/4/2009)...illion Americans are recruited annually to partici...for Human Research Protection (AHRP), and most wil...Research institutions view payments to volunteers ...ensation for potential risks related to participat...t volunteers have a very different view of clinica...
(Date:12/4/2009)... pressure from federal regulators to crack down on... Dec. 4 (HealthDay News) -- The makers of 24 diffe...federal regulators with plans to curb the abuse of...anies have been under pressure from U.S. Food and ...p the hundreds of fatal overdoses that occur with ...
(Date:12/4/2009)...sterol-lowering drugs known as statins are among t... study by researchers at Fred Hutchinson Cancer Re...tem cell transplant patients from one of the most ...erapy: graft-versus-host disease, or GVHD. The fin...the journal Blood . , In a retrospective study o...
(Date:12/4/2009)...SON, Wis., Dec. 4 When t...isconsin Department of Health Services needed to g...an ever before. Join Sonic Foundry, Inc. (Nasdaq...edia webcasting and knowledge management, for a li...Department of Health Services, will share how in-h...
...is less challenging for patients but equally effec... , TUESDAY, March 18 (HealthDay News) -- ...doses appears to be just as effective as conventio... the patient receives is actually less, though tre...
...O, March 18 W. Scott Harkonen,M.D., the former CE...d,felony Food, Drug and Cosmetic Act charges for h... and misleading information about the efficacy of,... indictment alleges that Harkonen, a medical docto...
...ES, N.J., March 18 BD (Becton,Dickinson and Compa...ted John,R. Considine as Vice Chairman and Chief F...f Directors, effective immediately. Mr. Considine ...e,independent with the exception of Mr. Considine ...
...lif., March 18 Transdel,Pharmaceuticals, Inc. (OT...l company focused on the development and commercia...dications, today announced that Dr.,Juliet Singh, ... Eastern Time at The Marriott Copley Place in Bost...
...ch 18 /PRNewswire-FirstCall/ - Novadaq(R) Technolo...ical imaging systems and image,guided therapies fo...and,live webcast on Tuesday, March 25, 2008 at 4:3..., dial 416-644-3417 or,1-800-732-6179. Please conn...
...group says estimate would effectively strain healt...hDay News) -- An estimated 10 million American bab...r lifetime, placing enormous strains on the U.S. h...lzheimer,s, including 200,000 to 250,000 people un...
(Date:12/4/2009)...Newswire-FirstCall/ -- AstraZeneca (NYSE: AZN ) ...ration (FDA) has approved once-daily SEROQUEL XR...s as adjunctive (add-on) treatment to antidepressa.... SEROQUEL XR is the only medication in its class ... disorder as adjunctive therapy and acute depressi...
(Date:12/3/2009)...swire-FirstCall/ -- A genetic variation that may i...ly life-threatening blood disorder if exposed to c...e of several medical discoveries scientists at can...DGX ) will present during the 51st American Societ...n, December 5-8, 2009, in New Orleans, LA. ,, ...
(Date:12/3/2009)...PRNewswire/ -- ParagonRx, a Delaware-based company...d optimal medication use, will host a free webinar... on REMS - Risk Evaluation Mitigation Strategy - p...nagement. Dr. Gary Slatko, chief medical officer ...ment programs, will lead the one-hour program begi...
...Newswire-FirstCall/ - Alfacell Corporation,(Nasdaq...n the International,Journal of Oncology (2007; Vol...ubstantially decreases reactive oxygen intermediat.... The observed antioxidant activity,of ONCONASE ma...ells and,mechanistic synergism with other anti-can...
...ngle, Higher, More Concentrated Dose of ...f., Aug. 22 Nuvelo, Inc.,(Nasdaq: NUVO ) today a...NOMA-3 (Speedy Opening of Non-functional and Occlu...evaluating lead product candidate,alfimeprase, for...n (CO). This open-label, single-arm trial will ev...
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...